Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin (Q41685708)
Jump to navigation
Jump to search
scientific article published on 28 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin |
scientific article published on 28 October 2014 |
Statements
1 reference
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin (English)
1 reference
Julio Rosenstock
1 reference
Lars Hansen
1 reference
Pamela Zee
1 reference
Yan Li
1 reference
William Cook
1 reference
Boaz Hirshberg
1 reference
Nayyar Iqbal
1 reference
28 October 2014
1 reference
1 reference
Identifiers
1 reference